Vaxcyte’s $100 Million Shares Offering

Latham & Watkins represented the underwriters in the transaction. Vaxcyte, Inc. (Nasdaq: PCVX), a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Chaos’ Merger With Enscape

Latham & Watkins represented TA Associates in the transaction, while Schoenherr advised Chaos. TA Associates, a global growth private equity firm, closed its agreement with LEA...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Medtronic’s Acquisition of Affera

Latham & Watkins represented Affer in the transaction. Medtronic plc (NYSE:MDT), a global leader in healthcare technology, has announced that it has entered into a definitive agreement...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Kudu Investment Management’s Minority Investment in Radcliffe Capital Management

Seward & Kissel represented Kudu Investment Management on the deal, while Dechert advised Radcliffe Capital Management. Radcliffe Capital Management, L.P. (Radcliffe), an SEC-registered investment adviser specializing...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here